Medicare drug coverage

XIFAXAN in Idaho: 2027 Part D coverage

45 of 45 Part D plans offered in Idaho (100%) list XIFAXAN on their 2027 formulary, the plan's list of covered drugs (the same share as 2026). 100% of those require prior authorization, step therapy, or a quantity limit. Plan counts include both Medicare Advantage plans with drug coverage (37 MA-PD) and stand-alone drug plans (8 PDP).

License: a US government work, in the public domain (Public Domain Mark 1.0).

For pharmacies and agencies: check a whole drug list against 2027 formularies.

Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.

Every 2027 plan in Idaho

Each Part D plan offered in Idaho, with XIFAXAN's 2026 and 2027 tier and its 2027 limits. A tier is the cost level a plan puts a drug on; a lower tier usually costs less. Enter a ZIP to see only the plans offered in that county.

Runs on this page. No account, and the ZIP is not stored.

PA is prior authorization (the plan must approve it first), ST is step therapy (try another drug first), and QL is a quantity limit. D-SNP, C-SNP, and I-SNP are Special Needs Plans: for people with both Medicare and Medicaid, with certain chronic conditions, or who live in a nursing home or need that level of care. Plans are listed by plan ID.

XIFAXAN, 2027 Part D plans, in plan ID order
PlanPlan IDType2026 tier2027 tier2027 PA / ST / QLChange
UHC Nursing Home Plan ID-F1 (PPO I-SNP)H0710-074-000MA-PD (PPO I-SNP)New plan IDTier 3PANew plan ID in 2027
True Blue Rx 32PSP (HMO)H1350-032-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
True Blue Rx 33 (HMO)H1350-033-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
True Blue Rx 34 (HMO)H1350-034-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
True Blue Rx 35PSP (HMO)H1350-035-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
True Blue Rx 36 (HMO)H1350-036-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
True Blue Rx 37 (HMO)H1350-037-000MA-PD (HMO)Tier 5Tier 3PA, QLTier 5 to 3
UHC Complete Care Support ID-1A (PPO C-SNP)H2001-050-000MA-PD (PPO C-SNP)Tier 4Tier 3PATier 4 to 3
AARP Medicare Advantage from UHC ID-0001 (PPO)H2406-044-000MA-PD (PPO)Tier 4Tier 3PATier 4 to 3
AARP Medicare Advantage from UHC ID-0003 (PPO)H2406-065-000MA-PD (PPO)Tier 4Tier 3PATier 4 to 3
Humana Gold Plus H2486-005 (HMO)H2486-005-000MA-PD (HMO)Tier 4Tier 3PA, QLTier 4 to 3
St. Luke's Advantage Rx 01 (HMO)H3012-001-000MA-PD (HMO)New plan IDTier 3PA, QLNew plan ID in 2027
St. Luke's Advantage Rx 02 (HMO)H3012-002-000MA-PD (HMO)New plan IDTier 3PA, QLNew plan ID in 2027
St. Luke's Advantage Rx 03 (HMO)H3012-003-000MA-PD (HMO)New plan IDTier 3PA, QLNew plan ID in 2027
PacificSource Medicare River Select Rx (HMO-POS)H3864-049-000MA-PD (HMO-POS)New plan IDTier 3QLNew plan ID in 2027
UHC Dual Complete ID-Y1 (HMO-POS D-SNP)H4032-001-000MA-PD (HMO-POS D-SNP)Tier 4Tier 3PATier 4 to 3
UHC Dual Complete ID-QV1 (HMO-POS D-SNP)H4032-002-000MA-PD (HMO-POS D-SNP)Tier 4Tier 3PATier 4 to 3
UHC Dual Complete ID-YL (HMO-POS D-SNP)H4032-003-000MA-PD (HMO-POS D-SNP)New plan IDTier 3PANew plan ID in 2027
American Health Advantage of Idaho (HMO I-SNP)H4232-003-000MA-PD (HMO I-SNP)Tier 1Tier 1QLRemoved PA
AARP Medicare Advantage from UHC ID-0005 (HMO-POS)H4604-012-000MA-PD (HMO-POS)Tier 4Tier 3PATier 4 to 3
AARP Medicare Advantage from UHC ID-0006 (HMO-POS)H4604-013-000MA-PD (HMO-POS)Tier 4Tier 3PATier 4 to 3
AARP Medicare Advantage from UHC ID-0007 (HMO-POS)H4604-014-000MA-PD (HMO-POS)Tier 4Tier 3PATier 4 to 3
AARP Medicare Advantage from UHC ID-0008 (HMO-POS)H4604-020-000MA-PD (HMO-POS)Tier 4Tier 3PATier 4 to 3
AARP Medicare Advantage from UHC ID-0009 (HMO-POS)H4604-022-000MA-PD (HMO-POS)Tier 4Tier 3PATier 4 to 3
UHC Complete Care ID-12 (HMO-POS C-SNP)H4604-024-000MA-PD (HMO-POS C-SNP)Tier 4Tier 3PATier 4 to 3

Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.

Idaho compared with the nation

100% of the 45 Part D plans offered in Idaho leave XIFAXAN off the 2027 formulary or restrict it, against 97% nationally (3 points higher). Idaho ranks 6 of 51 states from most to least restrictive; it shares its 100% with 38 other states, and the prior authorization or step therapy share sets the order among them. A plan offered in several states counts in each.

XIFAXAN in every state and by parent organization

2027 compared with 2026

XIFAXAN Part D coverage, 2026 and 2027
Measure20262027Change
Part D plans in the file5045-5
Plans that list it50 (100%)45 (100%)no change
Prior authorization (of plans that list it)50 (100%)41 (91%)-9 points
Step therapy (of plans that list it)0 (0%)0 (0%)no change
Quantity limit (of plans that list it)24 (48%)29 (64%)+16 points
Any of the three (of plans that list it)50 (100%)45 (100%)no change
Not listed or restricted (of all plans)50 (100%)45 (100%)no change

Formulary tier

XIFAXAN formulary tier, 2026 and 2027
Tier2026 plans2027 plans
Tier 11 (2%)1 (2%)
Tier 20 (0%)2 (4%)
Tier 30 (0%)42 (93%)
Tier 433 (66%)0 (0%)
Tier 516 (32%)0 (0%)

Plan by plan, 2026 to 2027

XIFAXAN: plans in both 2026 and 2027
Plan by planPlans
Same plan ID in both years36
Listed it in 2026, not in 20270 (0%)
Listed it in 2027, not in 20260 (0%)
Moved it to a higher tier0 (0%)
Moved it to a lower tier35 (97%)
Added prior authorization0 (0%)
Added step therapy0 (0%)
Added a quantity limit2 (6%)
Added at least one of the three2 (6%)
Removed at least one of the three3 (8%)
Plan IDs new in 20279
2026 plan IDs not in the 2027 file14

The CMS summary has no count of tier moves down, so "Moved it to a lower tier" is counted from the plan rows on this page: plans with the same plan ID in both years that list XIFAXAN both years.

XIFAXAN in other states

About this data

A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.

A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.

Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page

Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page

Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page

Source: CMS CY2026 landscape file, as of September 25, 2025. Publisher page

Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page

Source: US Census Bureau 2020 ZCTA to county relationship file (ZIP lookup), as of December 9, 2021. Publisher page

Try it on your own data today.

Free to start. Most teams are using it the same day.